(Q40153372)

English

Biomedical nanocomposites of hydroxyapatite/polycaprolactone obtained by surfactant mediation

scientific article published on October 2007

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

18 September 2017

Biomedical nanocomposites of hydroxyapatite/polycaprolactone obtained by surfactant mediation (English)

1 reference

stated in

Europe PubMed Central

18 September 2017

0 references

Hae-Won Kim

1

1 reference

stated in

Europe PubMed Central

18 September 2017

1 October 2007

1 reference

stated in

Europe PubMed Central

18 September 2017

Journal of Biomedical Materials Research Part A

1 reference

stated in

Europe PubMed Central

18 September 2017

83

1 reference

stated in

Europe PubMed Central

18 September 2017

1

1 reference

stated in

Europe PubMed Central

18 September 2017

169-177

1 reference

stated in

Europe PubMed Central

18 September 2017

Poly-epsilon-caprolactone/hydroxyapatite composites for bone regeneration: in vitro characterization and human osteoblast response

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJBM.A.31247

retrieved

21 January 2018

Increased osteoblast function on PLGA composites containing nanophase titania

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FJBM.A.31247

retrieved

21 January 2018

Identifiers

DOI

10.1002/JBM.A.31247

1 reference

stated in

Europe PubMed Central

18 September 2017

1 reference

Europe PubMed Central

PubMed ID

17390319

retrieved

18 September 2017

(Q40153372)

Biomedical nanocomposites of hydroxyapatite/polycaprolactone obtained by surfactant mediation

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)